http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/medinatura-new-mexico-inc-expands-voluntary-nationwide-recall-reboost-nasal-spray-and-include

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/stuffbynainax-llc-issues-voluntary-nationwide-recall-mr7-super-700000-dietary-supplement-due

FDA Takes Action to Improve Recall Effectiveness Following Infant Botulism Outbreak Investigation Linked to ByHeart Infant Formula
http://www.fda.gov/news-events/press-announcements/fda-takes-action-improve-recall-effectiveness-following-infant-botulism-outbreak-investigation

FDA Eliminates Major Barrier to Using Real-World Evidence in Drug and Device Application Reviews
http://www.fda.gov/news-events/press-announcements/fda-eliminates-major-barrier-using-real-world-evidence-drug-and-device-application-reviews

FDA Proactively Awards National Priority Voucher Based on Strong Phase 3 Study Results
http://www.fda.gov/news-events/press-announcements/fda-proactively-awards-national-priority-voucher-based-strong-phase-3-study-results

FDA Approves Two Oral Therapies to Treat Gonorrhea
http://www.fda.gov/news-events/press-announcements/fda-approves-two-oral-therapies-treat-gonorrhea

FDA Proposes Expanding Sunscreen Active Ingredient List
http://www.fda.gov/news-events/press-announcements/fda-proposes-expanding-sunscreen-active-ingredient-list

http://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/early-alert-anesthesia-system-issue-ge-healthcare

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/medinatura-new-mexico-inc-issues-voluntary-nationwide-recall-reboost-nasal-spray-due-microbial

FDA Approves First Gene Therapy Treatment for Wiskott-Aldrich Syndrome
http://www.fda.gov/news-events/press-announcements/fda-approves-first-gene-therapy-treatment-wiskott-aldrich-syndrome